- Presentations
- 2
- Markets
- 1
Calquence is a brand of Acalabrutinib marketed by AstraZeneca Pharmaceuticals, with 2 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Acalabrutinib
- Brand owner
- AstraZeneca Pharmaceuticals
- Registered in
- United States
- Strengths and forms
- 100 mg capsule, 100 mg tablet
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Calquence 100 mg capsuleOral | AstraZeneca Pharmaceuticals | US FDA | Available on request |
| Calquence 100 mg tabletOral | AstraZeneca Pharmaceuticals | US FDA | Available on request |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Calquence
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.